Key Takeaways
- Nine quantum computing companies will receive $2 billion in federal grants from the Trump Administration, which will also take equity positions in each firm.
- Despite being the largest publicly traded pure-play quantum computing company, IonQ was excluded from the grant recipients list.
- Competitors including D-Wave Quantum (QBTS), Rigetti Computing (RGTI), and Infleqtion (INFQ) secured $100 million each, while IBM received a $1 billion allocation.
- Shares of IonQ climbed approximately 9.5% Thursday morning despite the exclusion, though the company continues to face projected losses extending years ahead.
- According to MarketBeat data, Wall Street maintains a “Moderate Buy” consensus rating on IonQ with a mean price target of $68.63.
In its most recent quarterly report, IonQ delivered revenue of $64.67 million — representing a massive 754.7% year-over-year increase — yet fell short on earnings expectations with a loss of $0.34 per share compared to the anticipated $0.26 loss.
Opening Thursday around $52.53, IONQ shares climbed roughly 9.5% despite the company’s absence from a significant federal funding initiative. This counterintuitive market reaction exemplifies the unpredictable nature of quantum computing equities — fascinating for observers but challenging for financial modeling.
According to an exclusive report from The Wall Street Journal, the Trump Administration’s initiative allocates $2 billion across nine quantum computing enterprises. Additionally, the federal government will acquire equity positions in each recipient, creating aligned financial incentives moving forward.
IBM claims the lion’s share with $1 billion of the funding pool. Globalfoundries secures $375 million. D-Wave, Rigetti, and Infleqtion each obtain $100 million allocations. The balance flows to several private entities, including a firm with partial ownership by Donald Trump Jr.’s 1789 Capital.
IonQ received nothing.
Implications of Federal Funding for Competing Firms
The government’s equity stakes represent more than capital infusions for recipients — they establish direct federal interests in these companies’ success. This creates a competitive structural advantage that IonQ’s rivals now possess.
D-Wave (QBTS) soared more than 24%, Rigetti (RGTI) leaped nearly 25%, and Infleqtion (INFQ) rallied over 30% following the announcement. IBM advanced close to 8%.
The puzzling question for market watchers is IonQ’s positive performance despite the exclusion. One plausible explanation: the government’s substantial commitment legitimizes the broader quantum computing sector, creating a rising tide effect — benefiting even companies outside the funding circle.
Analyst Sentiment on IonQ
Currently, ten analysts maintain Buy recommendations on IONQ. Six rate it as Hold, with one Sell rating. The overall consensus lands at “Moderate Buy” with a $68.63 average price target.
However, not all analysts share this optimism. Morgan Stanley holds a $48.50 price objective, while DA Davidson slashed its target from $55 down to $35 with a neutral stance in February.
The company commands a market capitalization near $19.6 billion, exhibits a beta of 3.05, and trades within a 52-week range spanning $25.89 to $84.64. The 50-day moving average rests at $39.31.
Institutional ownership has expanded recently. DNB Asset Management increased its IonQ position by more than 1,099% during Q4, accumulating 55,230 shares valued at approximately $2.48 million. Multiple other institutional investors have similarly established or expanded positions.
Regarding insider transactions, Director William Teuber purchased 3,000 shares at $38.38 in late February. Over the past quarter, insiders collectively divested 12,354 shares totaling $504,428.
Wall Street’s consensus full-year EPS projection stands at -$1.99, indicating persistent losses for the foreseeable future.





